Phosphorylated neurofilament subunit levels in the serum of cervical compressive myelopathy patients.
Phosphorylated neurofilament subunit levels in the serum of cervical compressive myelopathy patients.
复制标题
颈椎压迫性脊髓病患者血清中磷酸化神经丝亚基的水平。
DOI:
10.1016/j.jocn.2015.03.047
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Ogata T
中科院分区:
文献类型:
--
作者:
Kato S;Chikuda H;Ohya J;Hayakawa K;Takeshita K;Tanaka S;Ogata T
We investigated the serum levels of the phosphorylated form of the high molecular weight neurofilament subunit (pNF-H) in patients with cervical compressive myelopathy. pNF-H is becoming increasingly recognized as a biomarker for axonal injury, however, it remains unclear whether serum pNF-H is elevated in chronic spinal cord compression. We examined 26 patients who underwent surgery for cervical compressive myelopathy. Peripheral blood samples were obtained both preoperatively and 1 week after surgery to evaluate the serum pNF-H levels using an enzyme-linked immunosorbent assay. A history of recent aggravation of myelopathy was also investigated. Of the 26 myelopathy patients, the preoperative serum pNF-H level was negative in 20 patients and moderately elevated in six. Patients who were positive for pNF-H were more likely to have had a recent aggravation of myelopathy compared with the pNF-H negative patients (83versus25%; p = 0.02). All patients who were positive for pNF-H before surgery remained positive after surgery. Two patients who became positive after surgery demonstrated a neurologic deterioration associated with the surgery. In conclusion, the serum pNF-H level was negative in the majority of patients with cervical compressive myelopathy. Our results suggest that an elevated serum level of pNF-H is associated with an acute worsening of myelopathy and that a positive conversion of pNF-H after surgery is a marker of perioperative neural damage.